Oulu Wang

Oulu (Lulu) Wang, Ph.D., practices all aspects of patent-related work in the life sciences industry, including patent prosecution, strategic counseling, post-grant proceedings, and litigation. With a doctorate in neurobiology from Harvard Medical School, she focuses on combining technical expertise and legal insight into compelling strategies tailored to client needs.

Lulu prepares and prosecutes patent applications, provides freedom-to-operate and patentability opinions, and represents clients in appeals and post-grant proceedings such as inter partes reviews (IPRs) before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO).

Lulu represents innovative companies in various pre-litigation and litigation matters. Her experience includes developing infringement, validity, and claim construction positions; preparing for depositions; working with experts; and litigating under the Biologics Price Competition and Innovation Act (BPCIA).

Lulu has managed and defended patent portfolios for clients in diverse technologies, including biologics, diagnostics, endocrinology, gene editing and CRISPR, gene therapy, immunology, microbiology, neuroscience, oncology, recombinant organisms, and synthetic biology.

Lulu practiced at Finnegan as a technical specialist and a student associate while attending Harvard Law School, where she received the 2016 Dean’s Scholar Prize in Legal Research and Writing.

Education :

• Harvard Law School J.D., 2018
• Harvard Medical School Ph.D., Neurobiology, 2012
• Harvard College B.A., Biology, with honors, 2006

Admissions :

• Massachusetts
• U.S. Patent and Trademark Office

Professional Activities :

• Boston Patent Law Association
• American Bar Association (vice chair, Patents in the Chemical and Life Sciences Committee, Section of Intellectual Property Law, 2019-2020)